Cytori Therapeutics, Inc. (CYTX) Release: Multicenter Investigator-Sponsored Cell Therapy Study for Peripheral Artery Disease Approved in Japan  
9/13/2012 10:04:11 AM

SAN DIEGO--(BUSINESS WIRE)--Cytori Therapeutics (NASDAQ: CYTX) today announced that a 40-patient, multi-center investigator-sponsored and funded clinical study in Japan using the Celution® System has been approved under the Ministry of Health, Labor and Welfare (MHLW) Guidelines on Clinical Research Using Human Stem Cells.